Galectin Therapeutics, Inc.
$12 M
Secondary/Follow-On
Sole Book-Runner
Arlington Asset Investment Corp.
$41.9 M
Secondary/Follow-On
Co-Manager
BGS Acquisition Corp.
$40 M
IPO
Co-Manager
NetSol Technologies, Inc.
$6.7 M
Secondary/Follow-On
Sole Book-Runner
InVivo Therapeutics Holdings, Inc.
$20 M
Secondary/Follow-On
Joint Book-Runner
GSV Capital Corp.
$90 M
Secondary/Follow-On
Co-Manager
Comstock Mining
$17.3 M
Secondary/Follow-On
Joint Book-Runner
Comstock Mining
$17.3 M
Secondary/Follow-On
Joint Book-Runner
ChromaDex Corporation
$11.2 M
Registered Direct
Sole Book-Runner
Synergy Pharmaceuticals, Inc.
$17.3 M
Follow-on Direct
Sole Book-Runner
New York Mortgage Trust, Inc.
$16.6 M
Follow-on Direct
Co-Manager
Selway Capital Acquisition Corp.
$20 M
IPO
Sole Book-Runner